McCowan Caitlin V, Salmon Duncan, Hu Jingzhe, Pudakalakatti Shivanand, Whiting Nicholas, Davis Jennifer S, Carson Daniel D, Zacharias Niki M, Bhattacharya Pratip K, Farach-Carson Mary C
Department of Electrical and Computer Engineering, Rice University, Houston, TX 77005, USA.
Department of Diagnostic and Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center, Houston, TX 77054, USA.
Diagnostics (Basel). 2022 Mar 1;12(3):610. doi: 10.3390/diagnostics12030610.
Medical imaging devices often use automated processing that creates and displays a self-normalized image. When improperly executed, normalization can misrepresent information or result in an inaccurate analysis. In the case of diagnostic imaging, a false positive in the absence of disease, or a negative finding when disease is present, can produce a detrimental experience for the patient and diminish their health prospects and prognosis. In many clinical settings, a medical technical specialist is trained to operate an imaging device without sufficient background information or understanding of the fundamental theory and processes involved in image creation and signal processing. Here, we describe a user-friendly image processing algorithm that mitigates user bias and allows for true signal to be distinguished from background. For proof-of-principle, we used antibody-targeted molecular imaging of colorectal cancer (CRC) in a mouse model, expressing human MUC1 at tumor sites. Lesion detection was performed using targeted magnetic resonance imaging (MRI) of hyperpolarized silicon particles. Resulting images containing high background and artifacts were then subjected to individualized image post-processing and comparative analysis. Post-acquisition image processing allowed for co-registration of the targeted silicon signal with the anatomical proton magnetic resonance (MR) image. This new methodology allows users to calibrate a set of images, acquired with MRI, and reliably locate CRC tumors in the lower gastrointestinal tract of living mice. The method is expected to be generally useful for distinguishing true signal from background for other cancer types, improving the reliability of diagnostic MRI.
医学成像设备通常使用自动处理来创建和显示自归一化图像。如果执行不当,归一化可能会错误呈现信息或导致分析不准确。在诊断成像中,在没有疾病时出现假阳性,或在存在疾病时出现阴性结果,可能会给患者带来有害体验,并降低他们的健康前景和预后。在许多临床环境中,医学技术专家在没有足够背景信息或对图像创建和信号处理所涉及的基本理论及过程缺乏理解的情况下接受培训来操作成像设备。在此,我们描述了一种用户友好的图像处理算法,该算法可减轻用户偏差并能区分真实信号与背景。为了进行原理验证,我们在小鼠模型中对结直肠癌(CRC)进行了抗体靶向分子成像,肿瘤部位表达人粘蛋白1(MUC1)。使用超极化硅颗粒的靶向磁共振成像(MRI)进行病变检测。然后对包含高背景和伪影的所得图像进行个性化图像后处理和对比分析。采集后图像处理允许将靶向硅信号与解剖质子磁共振(MR)图像进行配准。这种新方法允许用户校准一组通过MRI获取的图像,并可靠地在活体小鼠的下胃肠道中定位CRC肿瘤。预计该方法对于区分其他癌症类型的真实信号与背景、提高诊断MRI的可靠性普遍有用。